Aytu Biopharma, Inc financial data

Symbol
AYTU on Nasdaq
Location
7900 E. Union Avenue, Suite 920, Denver, CO
Fiscal year end
June 30
Latest financial report
10-Q - Q3 2025 - Nov 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 99.8 % -0.73%
Quick Ratio 16.6 % -10.3%
Debt-to-equity 253 % +55.6%
Return On Equity -61.9 % +51.5%
Return On Assets -10.7 % -111%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.91M shares +61.2%
Common Stock, Shares, Outstanding 9.91M shares +61.2%
Entity Public Float 7.24M USD -32.4%
Common Stock, Value, Issued 1K USD 0%
Weighted Average Number of Shares Outstanding, Basic 9.44M shares +55.6%
Weighted Average Number of Shares Outstanding, Diluted 19.5M shares +114%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 63.7M USD -0.38%
Cost of Revenue 41.2M USD -6.27%
Research and Development Expense 900K USD -65.4%
Selling and Marketing Expense 20.6M USD -5%
General and Administrative Expense 17.2M USD -8.55%
Operating Income (Loss) -8.4M USD -408%
Nonoperating Income (Expense) -7.71M USD -424%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -13.3M USD -844%
Income Tax Expense (Benefit) 32K USD -98.7%
Net Income (Loss) Attributable to Parent -13.1M USD -109%
Earnings Per Share, Basic -2 USD/shares -92.1%
Earnings Per Share, Diluted -0.08 USD/shares +46.7%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 32.6M USD +62.3%
Accounts Receivable, after Allowance for Credit Loss, Current 33.2M USD +43.5%
Inventory, Net 10.1M USD -14%
Other Assets, Current 63.1M USD +4630%
Assets, Current 81.1M USD
Property, Plant and Equipment, Net 500K USD -27.7%
Operating Lease, Right-of-Use Asset 1.01M USD -17.6%
Intangible Assets, Net (Excluding Goodwill) 41.4M USD -19.1%
Goodwill 0 USD
Other Assets, Noncurrent 939K USD -52.4%
Assets 125M USD +7.91%
Accounts Payable, Current 12.3M USD -8.67%
Employee-related Liabilities, Current 3.95M USD -24.1%
Accrued Liabilities, Current 36.7M USD +8.83%
Liabilities, Current 66M USD +7.74%
Long-term Debt and Lease Obligation 10.4M USD +0.16%
Operating Lease, Liability, Noncurrent 1.02M USD -10.6%
Other Liabilities, Noncurrent 4.95M USD +0.65%
Liabilities 101M USD -0.92%
Retained Earnings (Accumulated Deficit) -332M USD -4.1%
Stockholders' Equity Attributable to Parent 23.2M USD -22.3%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 32.2M USD -33.5%
Liabilities and Equity 125M USD +7.91%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -618K USD +48.1%
Net Cash Provided by (Used in) Financing Activities 2.3M USD +152%
Net Cash Provided by (Used in) Investing Activities 0 USD -100%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 9.91M shares +61.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 1.68M USD +1545%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.8M USD +3.24%
Interest Paid, Excluding Capitalized Interest, Operating Activities 466K USD +27.3%
Deferred Tax Assets, Valuation Allowance 137M USD -0.51%
Deferred Tax Assets, Gross 137M USD -0.88%
Operating Lease, Liability 1.23M USD -24.8%
Depreciation 200K USD -71.4%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Lessee, Operating Lease, Liability, to be Paid 2.2M USD -16.1%
Property, Plant and Equipment, Gross 1.24M USD -51.7%
Operating Lease, Liability, Current 202K USD -58.3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 386K USD +2.39%
Lessee, Operating Lease, Liability, to be Paid, Year One 331K USD -17%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 351K USD -32.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 358K USD -7.25%
Deferred Tax Assets, Operating Loss Carryforwards 120M USD +0.51%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Unrecognized Tax Benefits 518K USD -60.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 230K USD -35.8%
Operating Lease, Payments 100K USD -50%
Additional Paid in Capital 355M USD +1.84%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 3.21M USD -12.9%
Depreciation, Depletion and Amortization 2.23M USD -3.09%
Deferred Tax Assets, Net of Valuation Allowance 252K USD -66.9%
Share-based Payment Arrangement, Expense 517K USD -76%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%